171 related articles for article (PubMed ID: 11069323)
1. Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol.
Väkeväinen S; Tillonen J; Salaspuro M; Jousimies-Somer H; Nuutinen H; Färkkilä M
Aliment Pharmacol Ther; 2000 Nov; 14(11):1511-8. PubMed ID: 11069323
[TBL] [Abstract][Full Text] [Related]
2. Effects of ALDH2 genotype, PPI treatment and L-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration.
Maejima R; Iijima K; Kaihovaara P; Hatta W; Koike T; Imatani A; Shimosegawa T; Salaspuro M
PLoS One; 2015; 10(4):e0120397. PubMed ID: 25831092
[TBL] [Abstract][Full Text] [Related]
3. Acetaldehyde production and other ADH-related characteristics of aerobic bacteria isolated from hypochlorhydric human stomach.
Väkeväinen S; Tillonen J; Blom M; Jousimies-Somer H; Salaspuro M
Alcohol Clin Exp Res; 2001 Mar; 25(3):421-6. PubMed ID: 11290854
[TBL] [Abstract][Full Text] [Related]
4. Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis.
Väkeväinen S; Mentula S; Nuutinen H; Salmela KS; Jousimies-Somer H; Färkkilä M; Salaspuro M
Scand J Gastroenterol; 2002 Jun; 37(6):648-55. PubMed ID: 12126241
[TBL] [Abstract][Full Text] [Related]
5. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
Bell NJ; Hunt RH
Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
Sharma VK
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers.
Kees F; Holstege A; Ittner KP; Zimmermann M; Lock G; Schölmerich J; Grobecker H
Aliment Pharmacol Ther; 2000 Apr; 14(4):407-12. PubMed ID: 10759619
[TBL] [Abstract][Full Text] [Related]
8. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
9. Safety profile of the proton-pump inhibitors.
Reilly JP
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119
[TBL] [Abstract][Full Text] [Related]
10. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
[TBL] [Abstract][Full Text] [Related]
12. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
Blandizzi C; Natale G; Gherardi G; Lazzeri G; Marveggio C; Colucci R; Carignani D; Del Tacca M
Dig Dis Sci; 1999 Oct; 44(10):2039-50. PubMed ID: 10548356
[TBL] [Abstract][Full Text] [Related]
13. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
[TBL] [Abstract][Full Text] [Related]
14. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
15. The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers.
Dammann HG; Burkhardt F; Wolf N
Aliment Pharmacol Ther; 1999 Sep; 13(9):1195-203. PubMed ID: 10468701
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
18. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
[TBL] [Abstract][Full Text] [Related]
19. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
